rs587780284

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2

The NM_000489.6(ATRX):​c.1438A>G​(p.Thr480Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000902 in 1,207,833 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 35 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 15/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. T480I) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.000036 ( 0 hom., 0 hem., cov: 23)
Exomes 𝑓: 0.000096 ( 0 hom. 35 hem. )

Consequence

ATRX
NM_000489.6 missense

Scores

16

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:2B:2

Conservation

PhyloP100: -0.354

Publications

2 publications found
Variant links:
Genes affected
ATRX (HGNC:886): (ATRX chromatin remodeler) The protein encoded by this gene contains an ATPase/helicase domain, and thus it belongs to the SWI/SNF family of chromatin remodeling proteins. This protein is found to undergo cell cycle-dependent phosphorylation, which regulates its nuclear matrix and chromatin association, and suggests its involvement in the gene regulation at interphase and chromosomal segregation in mitosis. Mutations in this gene are associated with X-linked syndromes exhibiting cognitive disabilities as well as alpha-thalassemia (ATRX) syndrome. These mutations have been shown to cause diverse changes in the pattern of DNA methylation, which may provide a link between chromatin remodeling, DNA methylation, and gene expression in developmental processes. Multiple alternatively spliced transcript variants encoding distinct isoforms have been reported. [provided by RefSeq, Jul 2017]
ATRX Gene-Disease associations (from GenCC):
  • alpha thalassemia-X-linked intellectual disability syndrome
    Inheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Labcorp Genetics (formerly Invitae), Orphanet, Ambry Genetics
  • ATR-X-related syndrome
    Inheritance: XL Classification: DEFINITIVE Submitted by: ClinGen
  • intellectual disability-hypotonic facies syndrome, X-linked, 1
    Inheritance: XL Classification: MODERATE Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.042601496).
BP6
Variant X-77683818-T-C is Benign according to our data. Variant chrX-77683818-T-C is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 128491.
BS2
High Hemizygotes in GnomAdExome4 at 35 XL gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ATRXNM_000489.6 linkc.1438A>G p.Thr480Ala missense_variant Exon 9 of 35 ENST00000373344.11 NP_000480.3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ATRXENST00000373344.11 linkc.1438A>G p.Thr480Ala missense_variant Exon 9 of 35 1 NM_000489.6 ENSP00000362441.4 P46100-1

Frequencies

GnomAD3 genomes
AF:
0.0000356
AC:
4
AN:
112369
Hom.:
0
Cov.:
23
show subpopulations
Gnomad AFR
AF:
0.0000323
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000564
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000438
AC:
8
AN:
182782
AF XY:
0.0000593
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000858
Gnomad OTH exome
AF:
0.000222
GnomAD4 exome
AF:
0.0000958
AC:
105
AN:
1095464
Hom.:
0
Cov.:
32
AF XY:
0.0000970
AC XY:
35
AN XY:
361008
show subpopulations
African (AFR)
AF:
0.0000379
AC:
1
AN:
26363
American (AMR)
AF:
0.00
AC:
0
AN:
35206
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
19363
East Asian (EAS)
AF:
0.00
AC:
0
AN:
30191
South Asian (SAS)
AF:
0.00
AC:
0
AN:
54071
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
40318
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4125
European-Non Finnish (NFE)
AF:
0.000123
AC:
103
AN:
839827
Other (OTH)
AF:
0.0000217
AC:
1
AN:
46000
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.485
Heterozygous variant carriers
0
5
10
14
19
24
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000356
AC:
4
AN:
112369
Hom.:
0
Cov.:
23
AF XY:
0.00
AC XY:
0
AN XY:
34541
show subpopulations
African (AFR)
AF:
0.0000323
AC:
1
AN:
30965
American (AMR)
AF:
0.00
AC:
0
AN:
10597
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2657
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3611
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2749
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
6123
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
238
European-Non Finnish (NFE)
AF:
0.0000564
AC:
3
AN:
53226
Other (OTH)
AF:
0.00
AC:
0
AN:
1519
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.563
Heterozygous variant carriers
0
1
2
2
3
4
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000130
Hom.:
1
Bravo
AF:
0.0000227
ExAC
AF:
0.0000741
AC:
9
EpiCase
AF:
0.00
EpiControl
AF:
0.000178

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:2Benign:2
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Alpha thalassemia-X-linked intellectual disability syndrome Uncertain:1Benign:1
Oct 28, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 24, 2020
Natera, Inc.
Significance:Uncertain significance
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

not provided Uncertain:1Benign:1
Jun 25, 2020
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jun 04, 2013
Genetic Services Laboratory, University of Chicago
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.062
BayesDel_addAF
Benign
-0.44
T
BayesDel_noAF
Benign
-0.68
CADD
Benign
3.0
DANN
Benign
0.60
DEOGEN2
Benign
0.0046
.;.;T;T;.
FATHMM_MKL
Benign
0.021
N
LIST_S2
Benign
0.65
T;.;T;T;T
M_CAP
Benign
0.078
D
MetaRNN
Benign
0.043
T;T;T;T;T
MetaSVM
Benign
-0.49
T
PhyloP100
-0.35
PrimateAI
Benign
0.21
T
PROVEAN
Benign
-0.42
N;N;.;.;.
REVEL
Benign
0.20
Sift
Benign
1.0
T;T;.;.;.
Sift4G
Benign
0.64
T;T;T;.;T
Polyphen
0.0010
B;.;.;.;.
Vest4
0.019
MutPred
0.082
Loss of phosphorylation at T480 (P = 0.0108);.;.;Loss of phosphorylation at T480 (P = 0.0108);.;
MVP
0.28
MPC
0.024
ClinPred
0.028
T
GERP RS
0.44
gMVP
0.13
Mutation Taster
=99/1
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs587780284; hg19: chrX-76939310; COSMIC: COSV64884996; COSMIC: COSV64884996; API